U.S. Sen. Bill Cassidy, a Louisiana Republican and outspoken critic of the 340B program, will lead the Senate committee tasked [...] …
Category: News Alert
Republicans reportedly clinched control of the U.S. House of Representatives on Wednesday, officially winning key races that put them over [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug purchases under the 340B program reached $66.3 billion in 2023, marking a 24% increase over the $54 billion in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry
A federal judge moments ago dismissed three drug industry challenges to Louisiana’s 340B contract pharmacy access law in another major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Vermont Democrat has introduced Senate legislation to codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...] …